Slate of Biotechs Heads to the Public Markets, Spurring Optimism

Eikon Therapeutics and Veradermics have gone public, with other biotechs poised to stage IPOs.
The Business Journals

These biotechs are in the market for a buyer

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Several Boston-area biotechs who ...
The Business Journals

More biotechs are shutting down as investors, executives clash over valuations

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min At least 17 Boston-area biotechs ...
Longview News-Journal

More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality

PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical ...
Longview News-Journal

Veeva Introduces Vault Basics for Biotechs

PLEASANTON, Calif., May 16, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Vault Basics, a new offering that includes technology, training, and support ...
Orange County Business Journal

Genzyme Results Lift Biotechs

Biotechnology company Genzyme Corp. said on Wednesday second-quarter earnings rose nearly 9% on higher sales of its drugs for rare and chronic diseases. Sign-up for our FREE Daily eNews update to get ...